Taylor, N. P. (2026). Analysts 'extremely bullish' as Telix beams into Novartis' territory with $1.6B ITM acquisition. FierceBiotech, N.PAG.
Chicago Style (17th ed.) CitationTaylor, Nick Paul. "Analysts 'Extremely Bullish' as Telix Beams into Novartis' Territory with $1.6B ITM Acquisition." FierceBiotech 2026: N.PAG.
MLA (9th ed.) CitationTaylor, Nick Paul. "Analysts 'Extremely Bullish' as Telix Beams into Novartis' Territory with $1.6B ITM Acquisition." FierceBiotech, 2026, p. N.PAG.
Warning: These citations may not always be 100% accurate.